Breast Cancer is the leading cause of cancer deaths in women. NIRAMAI is a deep tech start-up which has pioneered a new test for detecting early-stage breast cancer. Niramai Thermalytix is a radiation free, non-invasive, affordable, portable and privacy aware test for women of all age groups. The solution is based on their patented Artificial Intelligence algorithms which analyse temperature distribution on the skin to generate breast health report. The test has obtained all requisite regulatory clearances in India, Europe , USA and many countries in Africa and Asia. Niramai test is commercially available in over 280+ hospitals/diagnostic centres and screened about 280,000 women in India. The test is now commercial in 22+ countries including India, Philippines, UAE, Kenya, Sweden. Bulgaria, Turkey, UK and USA. Niramai holds 39 granted international patents (including 15 US grants and 14 Indian granted patents). Niramai is the most awarded startup from India, with 54 clinical publications in reputed journals To collaborate with Niramai, write to partnerships@niramai.com